APA (7th ed.) Citation

VBR, K., R, K., S, M., M, G., B, L., P, L., . . . A, K. (2025). CiPA-qualified human iPSC-derived cardiomyocytes: A new frontier in toxicity testing by evaluating drug-induced arrhythmias. Toxicology in vitro : an international journal published in association with BIBRA, 108, 106100. https://doi.org/10.1016/j.tiv.2025.106100

Chicago Style (17th ed.) Citation

VBR, Konala, Kuhikar R, More S, Gossmann M, Lickiss B, Linder P, Sarkar J, Bhanushali P, and Khanna A. "CiPA-qualified Human IPSC-derived Cardiomyocytes: A New Frontier in Toxicity Testing by Evaluating Drug-induced Arrhythmias." Toxicology in Vitro : An International Journal Published in Association with BIBRA 108 (2025): 106100. https://doi.org/10.1016/j.tiv.2025.106100.

MLA (9th ed.) Citation

VBR, Konala, et al. "CiPA-qualified Human IPSC-derived Cardiomyocytes: A New Frontier in Toxicity Testing by Evaluating Drug-induced Arrhythmias." Toxicology in Vitro : An International Journal Published in Association with BIBRA, vol. 108, 2025, p. 106100, https://doi.org/10.1016/j.tiv.2025.106100.